European Archives - Page 390 of 1015 - European Medical Journal

Continue
26 Apr 2022

When you choose Angiolite, you know who stands by you

Know more about Angiolite and the people who make it possible, because when you choose Angiolite, you know who stands by you…

Davidek Herron on digital transformation

Davidek Herron, Global Head of Digital at Roche, speaks to Isabel O’Brien about the myths surrounding digital transformation and much more.
9 Mins
25 Apr 2022

Editor's Pick: Adiposity and Neurological Disorders: A Review

Obesity and increased adipose tissue are linked with inflammation, the driving force behind neurologic disorders like Alzheimer’s disease…
25 Apr 2022

Treatment Landscape and Emerging Therapies in Oesophageal Cancer

This EMG-Health podcast, hosted by Brigitte Scott, explores the treatment landscape and emerging therapies in oesophageal cancer…
8 Mins
25 Apr 2022

Chronic Complications of Diabetes

Diabetes complications can lead to multiple comorbidities of the microvasculature and microvasculature including neuropathy…
22 Apr 2022

Chemotherapy Plus Immunotherapy as Bladder-Sparing Therapy for Muscle-Invasive Bladder Cancer

Comparing the efficacy of two bladder-sparing treatments: neoadjuvant chemotherapy plus immunotherapy versus chemotherapy alone…
22 Apr 2022

Can Asynchronous Telehealth Visits Effectively Treat Overactive Bladder?

Overactive bladder is a common condition that affects 20% of females, and substantially impairs quality of life…
9 Mins
22 Apr 2022

Prostate Artery Embolisation for Benign Prostatic Hyperplasia

BPH is the most common non-cancerous neoplasm of ageing males,1 increasing in incidence with age. The prevalence of BPH has been estimated…
April 2022

EMJ Urology 10 [Supplement 1] 2022

The use of prostate artery embolisation (PAE), a minimally invasive alternative to surgical treatment options, is explored in this review article, which offers an extensive overview of different management regimens and treatment approaches for benign prostatic hyperplasia (BPH).
22 Apr 2022

Solving the Mystery of PD-1 Inhibitors

Solved the mystery of how programmed cell death protein 1 (PD-1) inhibitors work on the immune system’s natural killer (NK) cells…